HomeIXC • ASX
add
Invex Therapeutics Ltd
Previous close
$0.10
Year range
$0.059 - $0.11
Market cap
7.52M AUD
Avg Volume
26.41K
P/E ratio
63.69
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 114.54K | -81.10% |
Operating expense | 233.10K | -45.57% |
Net income | -60.17K | -125.55% |
Net profit margin | -52.53 | -235.25% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.38M | -10.79% |
Total assets | 5.47M | -10.66% |
Total liabilities | 220.59K | -48.89% |
Total equity | 5.25M | — |
Shares outstanding | 75.15M | — |
Price to book | 1.43 | — |
Return on assets | -5.42% | — |
Return on capital | -5.65% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -60.17K | -125.55% |
Cash from operations | -205.48K | -224.23% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -215.70K | -240.36% |
Free cash flow | -74.10K | -161.37% |
About
Founded
2019
Website
